Tevogen Bio Holdings (TVGN) Enterprise Value (2021 - 2026)
Tevogen Bio Holdings (TVGN) reported Enterprise Value of -$692305.0 for Q1 2026, up 64.95% on a YoY basis from -$419717.7 in Q1 2025, and down 25.33% quarter-over-quarter from -$552372.0 in Q4 2025.
Tevogen Bio Holdings (TVGN) Enterprise Value (2021 - 2026) Analysis & Trends
Tevogen Bio Holdings has reported Enterprise Value for 6 years, with the latest figure at -$692305.0 in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 64.95% year-over-year to -$692305.0; the trailing twelve-month figure through Mar 2026 stood at -$692305.0 (up 64.95% YoY), and the FY2025 full-year result was -$552372.0, up 56.95% from the prior year.
- Enterprise Value for Q1 2026 stood at -$692305.0, down from -$552372.0 in the prior quarter.
- The five-year high for Enterprise Value was -$143047.0 in Q3 2022, with the low at -$5.7 million in Q1 2023.
- Historically, Enterprise Value has averaged -$1.8 million across 5 years, with a median of -$1.1 million in 2024.
- The largest YoY upside for Enterprise Value was 80.81% in 2023 against a maximum downside of 2350.54% in 2023.
- Tevogen Bio Holdings' Enterprise Value stood at -$5.5 million in 2022, then soared by 80.81% to -$1.1 million in 2023, then decreased by 21.91% to -$1.3 million in 2024, then surged by 56.95% to -$552372.0 in 2025, then slipped by 25.33% to -$692305.0 in 2026.
- The last three Enterprise Value figures came in at -$692305.0 (Q1 2026), -$552372.0 (Q4 2025), and -$1.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -584.73 Mn |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - | -692,305.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -692,305.00 |
| Dec 31, 2025 | -552,372.00 |
| Sep 30, 2025 | -1.04 Mn |
| Jun 30, 2025 | -685,229.00 |
| Mar 31, 2025 | -1.97 Mn |
| Dec 31, 2024 | -1.28 Mn |
| Sep 30, 2024 | -2.33 Mn |
| Jun 30, 2024 | -1.14 Mn |
| Mar 31, 2024 | -1.32 Mn |
| Dec 31, 2023 | -1.05 Mn |
| Sep 30, 2023 | -2.61 Mn |
| Jun 30, 2023 | -3.46 Mn |
| Mar 31, 2023 | -5.67 Mn |
| Dec 31, 2022 | -5.48 Mn |
| Sep 30, 2022 | -143,047.00 |
| Jun 30, 2022 | -185,645.00 |
| Mar 31, 2022 | -231,546.00 |
| Dec 31, 2021 | -344,581.00 |